Prophylaxis of Hematologic Complications With Naderin in First-Line Breast Cancer Chemotherapy

Clinical trial NCT07671547 · COMPLETED

Trial details

NCT number: NCT07671547
Sponsor: MIPO Clinic
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Breast Cancer Hematologic Disorder Leukopenia Chemotherapy-Induced Myelosuppression

Start date: 2014-01-01
Primary completion: 2015-12-31
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.